Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]

Value Health. 2018 Feb;21(2):146-154. doi: 10.1016/j.jval.2017.12.010.

Abstract

The fifth section of our Special Task Force report identifies and discusses two aggregation issues: 1) aggregation of cost and benefit information across individuals to a population level for benefit plan decision making and 2) combining multiple elements of value into a single value metric for individuals. First, we argue that additional elements could be included in measures of value, but such elements have not generally been included in measures of quality-adjusted life-years. For example, we describe a recently developed extended cost-effectiveness analysis (ECEA) that provides a good example of how to use a broader concept of utility. ECEA adds two features-measures of financial risk protection and income distributional consequences. We then discuss a further option for expanding this approach-augmented CEA, which can introduce many value measures. Neither of these approaches, however, provide a comprehensive measure of value. To resolve this issue, we review a technique called multicriteria decision analysis that can provide a comprehensive measure of value. We then discuss budget-setting and prioritization using multicriteria decision analysis, issues not yet fully resolved. Next, we discuss deliberative processes, which represent another important approach for population- or plan-level decisions used by many health technology assessment bodies. These use quantitative information on CEA and other elements, but the group decisions are reached by a deliberative voting process. Finally, we briefly discuss the use of stated preference methods for developing "hedonic" value frameworks, and conclude with some recommendations in this area.

Keywords: aggregation; cost-effectiveness; equity; multi-dimensioned benefits.

MeSH terms

  • Advisory Committees
  • Budgets*
  • Cost-Benefit Analysis / methods*
  • Decision Making*
  • Delivery of Health Care / economics*
  • Health Expenditures*
  • Health Policy
  • Health Priorities
  • Humans
  • Outcome Assessment, Health Care / methods*
  • Quality-Adjusted Life Years
  • Technology Assessment, Biomedical / economics*
  • United States